Sherry LaPorte

Sherry LaPorte has over 20 years of work experience in the biotechnology and pharmaceutical industry. Their most recent role is as a Principal/Director at The Strategy & Design Group since January 2023.

Before that, they worked at Santa Ana Bio, Inc as the VP of Antibody Development starting in August 2022. Prior to that, they served as the Director of Biotherapeutics Engineering at The Janssen Pharmaceutical Companies of Johnson & Johnson from July 2019.

From February 2018, Sherry held the position of Senior Director Biologics Lead Engineering at JBIO/Janssen. Sherry was also the Director of Antibody Research at Vivace Therapeutics, Inc. starting from February 2017.

In 2014, Sherry joined CytomX Therapeutics where they held two roles consecutively, as a Senior Scientist in Cancer Immunology and as a Research Scientist in Protein Engineering.

Their earlier experiences include working as a Principal Scientist at Pfizer from January 2007 to August 2011, as a Senior Scientist at Rinat Neuroscience in December 2006, and as a Postdoctoral Research Fellow at Stanford University from September 2004 to November 2006.

Sherry began their career as a Postdoctoral Fellow at UCSF at San Francisco General Hospital and worked there until August 2004.

Sherry LaPorte's education history includes a strong background in pharmaceutical sciences and biophysics. Sherry obtained their Bachelor's Degree in Pharmacy from the University of Connecticut, although the exact start and end years are not provided.

After completing their undergraduate studies, Sherry pursued further education at the University of California, San Francisco (UCSF). From 1993 to 2000, they obtained a PhD in Pharmaceutical Chemistry with a specialization in Biophysics. This suggests a comprehensive understanding of the chemistry behind pharmaceutics, particularly in relation to the structure and behavior of biological molecules.

Subsequently, Sherry engaged in post-doctoral research. Sherry first joined the University of California, San Francisco - School of Medicine in 2001 and concluded their post-doctoral work in 2003. During this period, they focused on Molecular Biology, further expanding their knowledge in the field.

Following their time at UCSF, Sherry pursued another post-doctoral position at the renowned Stanford University School of Medicine from 2003 to 2006. Their specialization during this period was Immunology, specifically in the area of Structural Biology. This demonstrates their research interests in studying the immune system at a molecular level, particularly examining the structures of immune-related molecules and their functions.

In addition to their academic achievements, Sherry also holds a Professional Licensed Pharmacist certification (R.Ph.) from the State of Connecticut. However, the specific details regarding when and where they obtained this certification are not provided.